Vanda Pharmaceuticals
VNDA
VNDA
172 hedge funds and large institutions have $611M invested in Vanda Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 67 increasing their positions, 59 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
172
Holders Change
-15
Holders Change %
-8.02%
% of All Funds
2.91%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
67
Reduced
59
Closed
25
Calls
$901K
Puts
$263K
Net Calls
+$638K
Net Calls Change
+$351K
Top Buyers
Top Sellers
1 |
![]()
1
LSV Asset Management
Chicago,
Illinois
|
$1.4M |
2 |
2
Bank of New York Mellon
New York
|
$6.72M |
3 |
3
Acadian Asset Management
Boston,
Massachusetts
|
$303K |
4 |
4
State Street
Boston,
Massachusetts
|
$40.5M |
5 |
![]()
5
JPMorgan Chase & Co
New York
|
$1.15M |